Related Experiment Videos
Observations on EGFR gene amplification and polymorphism in prostatic diseases.
V L Kumar1, P K Majumder, V Kumar
1Department of Pharmacology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi. kumarvl@medinst.ernet.in
International Urology and Nephrology
|November 1, 2000
Summary
Epidermal growth factor receptor (EGFR) gene amplification and polymorphism were studied in benign hypertrophy (BPH) and carcinoma (CaP). Amplification was noted in advanced BPH, and a specific DNA band was found in most prostate cancer cases.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The epidermal growth factor receptor (EGFR) is implicated in various cancers.
- Understanding EGFR gene alterations in prostate diseases is crucial for diagnosis and treatment.
Purpose of the Study:
- To investigate the amplification and polymorphism of the EGFR gene in benign prostatic hypertrophy (BPH) and prostate carcinoma (CaP).
- To correlate EGFR gene alterations with the type and progression of prostatic diseases.
Main Methods:
- Genomic DNA was analyzed from BPH and CaP patients.
- Southern blot analysis was performed after digestion with MspI and HpaII enzymes.
- EGFR gene amplification and specific DNA band presence were assessed.
Main Results:
- EGFR gene amplification was observed in grade IV BPH compared to grade II BPH.
- A 5kb DNA band, detected via Southern blot, was present in all CaP cases.
- This 5kb band was also found in one out of three BPH cases.
Conclusions:
- The study suggests a potential association between EGFR gene amplification and polymorphism and the progression of prostatic diseases.
- The identified 5kb DNA band may serve as a marker for prostate carcinoma.
- Further research is warranted to elucidate the role of EGFR alterations in prostate cancer development and progression.